Renaissance Technologies
NAGE

Renaissance Technologies’s Niagen Bioscience NAGE Stock Holding History

Renaissance Technologies’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Sell
659,584
-669,259
-50% -$2.72M ﹤0.01% 1928
2026
Q1 		$5.86M Buy
1,328,843
+414,725
+45% +$2.24M 0.01% 1285
2025
Q4 		$5.81M Buy
914,118
+201,118
+28% +$1.4M 0.01% 1210
2025
Q3 		$6.65M Buy
713,000
+223,400
+46% +$2.26M 0.01% 1322
2025
Q2 		$7.06M Sell
489,600
-33,500
-6% -$331K 0.01% 1299
2025
Q1 		$3.61M Sell
523,100
-189,688
-27% -$1.19M 0.01% 1627
2024
Q4 		$3.78M Buy
712,788
+288,588
+68% +$1.58M 0.01% 1621
2024
Q3 		$1.55M Buy
424,200
+8,100
+2% +$25.5K ﹤0.01% 2181
2024
Q2 		$1.14M Buy
416,100
+32,400
+8% +$108K ﹤0.01% 2254
2024
Q1 		$1.33M Sell
383,700
-85,602
-18% -$158K ﹤0.01% 2301
2023
Q4 		$671K Buy
469,302
+24,390
+5% +$34K ﹤0.01% 2632
2023
Q3 		$650K Sell
444,912
-15,627
-3% -$24.4K ﹤0.01% 2589
2023
Q2 		$723K Buy
460,539
+33,339
+8% +$49.8K ﹤0.01% 2680
2023
Q1 		$654K Sell
427,200
-143,700
-25% -$256K ﹤0.01% 2726
2022
Q4 		$959K Sell
570,900
-47,310
-8% -$75K ﹤0.01% 2559
2022
Q3 		$760K Sell
618,210
-121,690
-16% -$196K ﹤0.01% 2661
2022
Q2 		$1.24M Buy
739,900
+319,399
+76% +$625K ﹤0.01% 2567
2022
Q1 		$1.03M Buy
420,501
+382,413
+1,004% +$1.04M ﹤0.01% 2704
2021
Q4 		$142K Buy
+38,088
New +$206K ﹤0.01% 3616
2021
Q1 		– Sell
-235,200
Closed -$1.13M – 3791
2020
Q4 		$1.13M Buy
235,200
+153,819
+189% +$750K ﹤0.01% 2437
2020
Q3 		$326K Sell
81,381
-128,819
-61% -$621K ﹤0.01% 2967
2020
Q2 		$965K Buy
+210,200
New +$941K ﹤0.01% 2556
2019
Q4 		– Sell
-39,900
Closed -$157K – 3793
2019
Q3 		$157K Buy
+39,900
New +$170K ﹤0.01% 3201
2018
Q1 		– Sell
-45,100
Closed -$265K – 3624
2017
Q4 		$265K Buy
+45,100
New +$244K ﹤0.01% 3059

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies's NAGE Position: Q2 2026 in Review

Renaissance Technologies reduced its Niagen Bioscience (NAGE) stake by 50% in Q2 2026, selling an estimated $2.72M and leaving 659,584 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1928.

Renaissance Technologies first reported a position in NAGE in Q4 2017 and has held it in 24 quarters since. The position peaked at $7.06M in Q2 2025. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Renaissance Technologies held 659,584 shares of Niagen Bioscience worth $2.1M as of Q2 2026.
  • Renaissance Technologies sold 669,259 Niagen Bioscience shares in Q2 2026, an estimated $2.72M.
  • Niagen Bioscience made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1928 holding.
  • Renaissance Technologies first reported a position in Niagen Bioscience in Q4 2017 and has held it in 24 quarters since.
  • Renaissance Technologies's Niagen Bioscience position peaked at $7.06M in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.